# Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study

> **NCT04115072** · PHASE2,PHASE3 · COMPLETED · sponsor: **Regionshospital Nordjylland** · enrollment: 116 (actual)

## Conditions studied

- Schistosomiasis

## Interventions

- **DRUG:** Praziquantel 600Mg Oral Tablet x 5
- **DRUG:** Praziquantel 600Mg Oral Tablet x 1

## Key facts

- **NCT ID:** NCT04115072
- **Lead sponsor:** Regionshospital Nordjylland
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-03
- **Primary completion:** 2020-02-21
- **Final completion:** 2020-02-21
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2020-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115072, "Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04115072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*